General MedicationsOPHTHALMICStandard
NATACYN
NATAMYCIN
Standard Dose
5%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview NATACYN is listed in Drugs@FDA under application 050514 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient NATAMYCIN Form and strength SUSPENSION;OPHTHALMIC - 5% Sponsor HARROW EYE Submission history Latest submission status date: 2025-11-17 00:00:00.
Structured Monograph
Clinical summary
Approval overview NATACYN is listed in Drugs@FDA under application 050514 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient NATAMYCIN Form and strength SUSPENSION;OPHTHALMIC - 5% Sponsor HARROW EYE Submission history Latest submission status date: 2025-11-17 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.